Generex Biotechnology Company (NASDAQ: GNBT), a drugdelivery system and technology developer, has filed an offering by sellingstockholders of up to 74,475,861 shares of common stock. The proposed maximum aggregateoffering price is $78,199,653, but this…
Sun Healthcare Group (NASDAQ: SUNH) has filed for a mixed shelfoffering of $200 million this morning. They may periodically offer a combinationof common stock, preferred stock, debt securities, and warrants. The prospectusindicates the rehabilitation…
Today almost feels like the "March of Biotech-inguins" because most of the movers were small companies you might otherwise miss. Here were the big movers: Barrier Therapeutics (NASDAQ: BTRX) ran way up after first…
Genentech, Inc. (NYSE:DNA) and Biogen Idec, Inc. (Nasdaq:BIIB) came out this morning with some disappointing news. The biotech giants have announced that a Phase II/III study of Rituxan for lupus has failed to meet…
Merck (MRK) had high hopes for its cholesterol drug Cordaptive According to The Wall Street Journal, things did not work out. The paper reports that the agency issuing a "not approvable" letter for the…
Pharmacy benefits managers Express Scripts Inc. (NASDAQ: ESRX) and MedcoHealth Solutions Inc. (NASDAQ: MHS) are both set to report earnings on Tuesday. We’ll get to see earnings out of MedcoHealth Solutions Inc. (NASDAQ: MHS)…
Bristol-Myers Squibb (NYSE: BMY) has submitted an open shelf offering today for an undetermined amount. The offering includes a combination of debt securities, preferred stock, depositary shares, common stock, and warrants to be used…
Amgen (AMGN) adjusted earnings per share of $1.12 for the first quarter of 2008, an increase of 4 % compared to $1.08 for the first quarter of 2007. Adjusted net income decreased 4 %…
Bristol-Myers Squibb Company (NYSE: BMY) came out with earnings at $0.35 EPS and reaffirmed 2008 guidance of $1.36 to $1.46 GAAP EPS and $1.60 to $1.70 non-GAAP EPS. It also maintained a 2007 to…
Biogen Idec (NASDAQ: BIIB) is sliding marginally despite reported earnings today that showed a 23% increase in earnings riding on sales growth on Avonex and Rituxan. The earnings beat estimates and the company raised…
The FDA says it needs $70 million to inspect all of the foreign facilities it needs to so it can screen for dangerous drugs or drug components. The amount does not seem like much,…
GlaxoSmithKline (NYSE: GSK) has announced that it has entered into a definitive acquisition pact with Sirtris Pharmaceuticals Inc. (NASDAQ: SIRT). The drug giant will pay approximately $720 million via a cash tender offer of…
Amylin Pharmaceuticals (NASDAQ: AMLN) reported first quarter losses of $68.8 million, or $0.51 EPS, wider than the $49.4 million in the first quarter of 2007. Losses are credited to a drop in sales in…
Epocrates Inc. submitted an SEC filing to come public via an IPO Thursday night. The filing shows a proposed maximum aggregate offering price of $75 million, although this number is for filing purposes only.…
After today’s close, we’ll see earnings out of Intuitive Surgical, Inc. (NASDAQ: ISRG). The estimates for the DaVinci robotic surgical device maker from First Call are $0.98 EPS on $178.21 million in revenues. Next…